Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: A double-masked, environmental study of patient preference

Current Medical Research and Opinion

Volumn 20, Issue 8, 2004, Pages 1167-1173

  Leonardi, Andrea ^a   Zafirakis, Panayotis ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Diagnostic and Therapeutic Medical Center   (Greece)

Author keywords

Comfort; Ketotifen; Ocular allergy; Olopatadine; Patient preference

Indexed keywords

EYE DROPS; KETOTIFEN FUMARATE; OLOPATADINE;

ADOLESCENT; ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CHILD; CLINICAL TRIAL; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG PREFERENCE; DRUG USE; ENVIRONMENTAL FACTOR; EYE IRRITATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 4344693341     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125004321     Document Type: Article

References (19)

1. Abelson MB, Smith L, Chapin M. Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment. The Ocular Surface 2003;1:127-149
2. Hesselmar B, Aberg B, Eriksson B, Aberg N. Allergic rhinoconjunctivitis, eczema, and sensitization in two areas with differing climates. Pediatr Allergy Immunol. 2001;12:208-15
3. Selnes A, Odland JO, Bolle R, Holt J, Dotterud LK, Lund E. Asthma and allergy in Russian and Norweigian schoolchildren: results from two questionnaire-based studies in the Kola Peninsula, Russia, and northern Norway. Allergy. 2001;56:344-8
4. Ozdemir N, Ucgun I, Metintas S, Kolsuz M, Metintas M. The prevalence of asthma and allergy among university freshmen in Eskisehir, Turkey. Respir Med. 2000;94:536-41
5. Austin JB, Kaur B, Anderson HR, Burr M, Harkins LS, Strachan DP, Warner JO. Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC international study of asthma and allergies in childhood). Arch Dis Child. 1999;81:225-30
6. Strachan DP, Sibbald B, Weiland SK, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC). Pediatr Allergy Immunol. 1997;8:161-76
7. Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals. Ann Allergy Asthma Immunol 2001;87:311-8
8. Opatanol® 0.1% [package insert]. Milano, Italia: Alcon(R) 2002
9. Zaditen® 0.025% [package insert]. Origgio (Varese), Italia: Novaritis Farma S.p.A;2001
10. Yanni JM, Miller ST, Gamache DA, Spellman JM, Xu S, Sharif NA. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol. 1997 Dec; 79(6): 5451-5.
11. Leonardi A, Abelson MB. Double-masked, randomized, placebo-controlled study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans. Clin Ther. 2003;25:2539-52
12. Berdy GJ, Spangler DL, Bensch G, Berdy SS, Brusatti RC. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Clin Ther. 2000;22:826-33
13. Greiner JV, Mundorf T, Dubiner H, Lonsdale H, Lonsdale J, Casey R, Parver L, Kapik BM, Shams NB, Abelson MB. Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. Am J Ophthalmol. 2003;136:1097-105
14. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Adv Ther. 2002;19:161-9
15. Aguilar AJ. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate. Acta Ophthalmologica Scandinavica (Suppl) 2000:52-55
16. Artal MN, Luna JD, Discepola M. A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%. Acta Ophthalmol Scand Suppl. 2000;230:64-5
17. Bioulekas D, Damialis A, Papakosta D, et al. 15-year aeroallergen records. Their usefulness in Athens Olympics, 2004. Allergy 2003;58:933-38
18. Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real world comparison of efficacy and ocular comfort. Adv Ther. 2003;20:79-91
19. Brockman HL, Momsen MM, Knudtson JR, Miller ST, Graff G, Yanni JM. Interactions of olopatadine and selected antihistamines with model and natural membranes. Ocul Immunol Inflamm. 2003;11:247-68